17.2 USD
+0.05 (+0.29%)
17.2 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to ACHC. ACHC was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ACHC while its profitability can be described as average. ACHC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ACHC had positive earnings in the past year.
ACHC had a positive operating cash flow in the past year.
In multiple years ACHC reported negative net income over the last 5 years.
Each year in the past 5 years ACHC had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 1.67%, ACHC perfoms like the industry average, outperforming 54.46% of the companies in the same industry.
ACHC has a Return On Equity (3.44%) which is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 5.82%, ACHC is doing good in the industry, outperforming 60.40% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ACHC is in line with the industry average of 9.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.67% | ||
| ROE | 3.44% | ||
| ROIC | 5.82% |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
1.3 Margins
The Profit Margin of ACHC (3.29%) is better than 69.31% of its industry peers.
ACHC's Profit Margin has improved in the last couple of years.
The Operating Margin of ACHC (13.59%) is better than 82.18% of its industry peers.
In the last couple of years the Operating Margin of ACHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.59% | ||
| PM (TTM) | 3.29% | ||
| GM | N/A |
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACHC is destroying value.
ACHC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACHC has more shares outstanding
ACHC has a worse debt/assets ratio than last year.
2.2 Solvency
ACHC has an Altman-Z score of 1.16. This is a bad value and indicates that ACHC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.16, ACHC is not doing good in the industry: 67.33% of the companies in the same industry are doing better.
ACHC has a Debt/Equity ratio of 0.73. This is a neutral value indicating ACHC is somewhat dependend on debt financing.
ACHC has a Debt to Equity ratio (0.73) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.16 |
ROIC/WACC0.66
WACC8.87%
2.3 Liquidity
A Current Ratio of 1.44 indicates that ACHC should not have too much problems paying its short term obligations.
ACHC's Current ratio of 1.44 is in line compared to the rest of the industry. ACHC outperforms 53.47% of its industry peers.
A Quick Ratio of 1.43 indicates that ACHC should not have too much problems paying its short term obligations.
The Quick ratio of ACHC (1.43) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.43 |
3. Growth
3.1 Past
ACHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.21%.
Measured over the past years, ACHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.21% on average per year.
ACHC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.58%.
ACHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.45% yearly.
EPS 1Y (TTM)-26.21%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-20.88%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%4.41%
3.2 Future
The Earnings Per Share is expected to grow by 5.66% on average over the next years.
ACHC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.46% yearly.
EPS Next Y-23.46%
EPS Next 2Y-9.5%
EPS Next 3Y-4.18%
EPS Next 5Y5.66%
Revenue Next Year4.93%
Revenue Next 2Y5.79%
Revenue Next 3Y6.03%
Revenue Next 5Y8.46%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 6.64, the valuation of ACHC can be described as very cheap.
ACHC's Price/Earnings ratio is rather cheap when compared to the industry. ACHC is cheaper than 97.03% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.31, ACHC is valued rather cheaply.
ACHC is valuated cheaply with a Price/Forward Earnings ratio of 6.36.
Based on the Price/Forward Earnings ratio, ACHC is valued cheaply inside the industry as 97.03% of the companies are valued more expensively.
ACHC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.64 | ||
| Fwd PE | 6.36 |
4.2 Price Multiples
ACHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACHC is cheaper than 91.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.02 |
4.3 Compensation for Growth
A cheap valuation may be justified as ACHC's earnings are expected to decrease with -4.18% in the coming years.
PEG (NY)N/A
PEG (5Y)0.65
EPS Next 2Y-9.5%
EPS Next 3Y-4.18%
5. Dividend
5.1 Amount
No dividends for ACHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
17.2
+0.05 (+0.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners116.33%
Inst Owner Change9.13%
Ins Owners1.28%
Ins Owner Change2.96%
Market Cap1.59B
Revenue(TTM)3.27B
Net Income(TTM)107.36M
Analysts79
Price Target26.56 (54.42%)
Short Float %12.47%
Short Ratio3.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.19%
Min EPS beat(2)5.25%
Max EPS beat(2)17.12%
EPS beat(4)3
Avg EPS beat(4)5.03%
Min EPS beat(4)-12.21%
Max EPS beat(4)17.12%
EPS beat(8)6
Avg EPS beat(8)3.57%
EPS beat(12)9
Avg EPS beat(12)2.45%
EPS beat(16)12
Avg EPS beat(16)8.69%
Revenue beat(2)1
Avg Revenue beat(2)0.08%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)1.45%
Revenue beat(4)1
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)1.45%
Revenue beat(8)2
Avg Revenue beat(8)-1.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.68%
Revenue beat(16)5
Avg Revenue beat(16)-0.75%
PT rev (1m)-14.03%
PT rev (3m)-17.35%
EPS NQ rev (1m)-25.16%
EPS NQ rev (3m)-27.16%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.81%
Revenue NQ rev (1m)-2.94%
Revenue NQ rev (3m)-3.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.64 | ||
| Fwd PE | 6.36 | ||
| P/S | 0.49 | ||
| P/FCF | N/A | ||
| P/OCF | 4.74 | ||
| P/B | 0.51 | ||
| P/tB | 2.12 | ||
| EV/EBITDA | 6.02 |
EPS(TTM)2.59
EY15.06%
EPS(NY)2.7
Fwd EY15.71%
FCF(TTM)-3.76
FCFYN/A
OCF(TTM)3.63
OCFY21.08%
SpS35.36
BVpS33.79
TBVpS8.11
PEG (NY)N/A
PEG (5Y)0.65
Graham Number44.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.67% | ||
| ROE | 3.44% | ||
| ROCE | 7.53% | ||
| ROIC | 5.82% | ||
| ROICexc | 5.94% | ||
| ROICexgc | 10.08% | ||
| OM | 13.59% | ||
| PM (TTM) | 3.29% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
ROICexc(3y)8.08%
ROICexc(5y)7.37%
ROICexgc(3y)16.06%
ROICexgc(5y)14.72%
ROCE(3y)10.25%
ROCE(5y)9.25%
ROICexgc growth 3Y-4.56%
ROICexgc growth 5Y16.02%
ROICexc growth 3Y1.65%
ROICexc growth 5Y14.56%
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.65 | ||
| Cap/Depr | 372.67% | ||
| Cap/Sales | 20.89% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.43% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.43 | ||
| Altman-Z | 1.16 |
F-Score4
WACC8.87%
ROIC/WACC0.66
Cap/Depr(3y)344.44%
Cap/Depr(5y)299.77%
Cap/Sales(3y)15.9%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.21%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-20.88%
EPS Next Y-23.46%
EPS Next 2Y-9.5%
EPS Next 3Y-4.18%
EPS Next 5Y5.66%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%4.41%
Revenue Next Year4.93%
Revenue Next 2Y5.79%
Revenue Next 3Y6.03%
Revenue Next 5Y8.46%
EBIT growth 1Y-18.4%
EBIT growth 3Y9.61%
EBIT growth 5Y10.7%
EBIT Next Year22.18%
EBIT Next 3Y12.52%
EBIT Next 5Y11.46%
FCF growth 1Y-499.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.13%
OCF growth 3Y-29.78%
OCF growth 5Y-15.9%
ACADIA HEALTHCARE CO INC / ACHC FAQ
What is the fundamental rating for ACHC stock?
ChartMill assigns a fundamental rating of 4 / 10 to ACHC.
Can you provide the valuation status for ACADIA HEALTHCARE CO INC?
ChartMill assigns a valuation rating of 6 / 10 to ACADIA HEALTHCARE CO INC (ACHC). This can be considered as Fairly Valued.
Can you provide the profitability details for ACADIA HEALTHCARE CO INC?
ACADIA HEALTHCARE CO INC (ACHC) has a profitability rating of 5 / 10.
How financially healthy is ACADIA HEALTHCARE CO INC?
The financial health rating of ACADIA HEALTHCARE CO INC (ACHC) is 2 / 10.
Is the dividend of ACADIA HEALTHCARE CO INC sustainable?
The dividend rating of ACADIA HEALTHCARE CO INC (ACHC) is 0 / 10 and the dividend payout ratio is 0%.